ASSESSMENT OF THE LEVEL OF PAIN IN THE TREATMENT OF PLANTAR FASCIITIS BY EXTRACORPOREAL SHOCK WAVE THERAPY

Autor: Ulkar Aslan Huseynova, Vasily V. Kozlov

Publikováno v: Siberian Journal of Life Sciences and Agriculture, Vol 16, Iss 2, Pp 349-358 (2024)

Background. Patellofemoral pain syndrome (PFPS) is a clinical condition characterized by retropatellar and/or peripatellar pain associated with activities associated with stress on the lower extremities (for example, walking, running, jumping, climbi

Externí odkaz: https://doaj.org/article/292bd0d1080b465fa14f0425887ecdaf

A Multiple Logistic Regression Model as an Additional Mathematical Method for Predicting the Development of Ischemic Stroke in Patients with Atrial Fibrillation

Autor: Natalya V. Aksyutina, Vladimir A. Shulman, Svetlana Yu. Nikulina, Vasily V. Kozlov, Oksana A. Gavrilyuk, Andrei V. Bespalov, Larissa G. Soinova, Eduard V. Semyonov

Publikováno v: International Journal of Biomedicine, Vol 8, Iss 4, Pp 284-287 (2018)

Prevention of thromboembolic complications in cases of atrial fibrillation (AF) and, above all, ischemic stroke (IS), represents a key problem of modern cardiology. The aim of the present study was to assess the feasibility of Multiple Logistic Regre

Externí odkaz: https://doaj.org/article/43a02261540948dd84e79155ae6bec7e

Promises and Hurdles of Medical Tourism Development in the Russian Federation

Autor: Arkady N. Daykhes, Mihajlo Jakovljevic, Vladimir A. Reshetnikov, Vasily V. Kozlov

Publikováno v: Frontiers in Psychology, Vol 11 (2020)

Background: Development of medical tourism improves access to healthcare in countries where the necessary medical procedures are not available or accessible to its citizens. In the country of destination, medical tourism stimulates economic developme

Externí odkaz: https://doaj.org/article/24ca763843b9458580eeb71aadf0e258

A systematic review and meta-analysis of placebo effect in clinical trials on chronic prostatitis/chronic pelvic pain syndrome.

Autor: Morozov A; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia., Bazarkin A; Institute for Clinical Medicine, Sechenov University, Moscow, Russia., Babaevskaya D; Institute for Clinical Medicine, Sechenov University, Moscow, Russia., Taratkin M; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia., Kozlov V; Department of Public Health and Healthcare, Sechenov University, Moscow, Russia., Suvorov A; 'Digital Biodesign and Personalized Healthcare' World-Class Research Center, Sechenov University, Moscow, Russia., Spivak L; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia., McFarland J; Institute of Linguistics and Intercultural Communication, Sechenov University, Moscow, Russia.; Faculty of Medicine, Universidad Autónoma Madrid, Madrid, Spain., Russo GI; Department of Surgery, Urology Section, University of Catania, Catania, Italy., Enikeev D; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.

Publikováno v: The Prostate [Prostate] 2022 May; Vol. 82 (6), pp. 633-656. Date of Electronic Publication: 2022 Feb 08.

MRI-derived PRECISE scores for predicting pathologically-confirmed radiological progression in prostate cancer patients on active surveillance.

Autor: Caglic I; CamPARI Prostate Cancer Group, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK., Sushentsev N; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK., Gnanapragasam VJ; Department of Urology, Addenbrooke's Hospital, Cambridge, UK.; Academic Urology Group, Department of Surgery, University of Cambridge, Cambridge, UK.; Cambridge Urology Translational Research and Clinical Trials Office, University of Cambridge, Biomedical Campus, Cambridge, CB2 0QQ, UK., Sala E; CamPARI Prostate Cancer Group, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK., Shaida N; CamPARI Prostate Cancer Group, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK., Koo BC; CamPARI Prostate Cancer Group, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK., Kozlov V; Department of Public Health and Healthcare Organisation, Sechenov First Moscow State Medical University, Moscow, Russia., Warren AY; CamPARI Prostate Cancer Group, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.; Department of Pathology, Addenbrooke's Hospital, Cambridge, UK., Kastner C; CamPARI Prostate Cancer Group, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.; Department of Urology, Addenbrooke's Hospital, Cambridge, UK., Barrett T; CamPARI Prostate Cancer Group, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK. tristan.barrett@addenbrookes.nhs.uk.; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK. tristan.barrett@addenbrookes.nhs.uk.

Publikováno v: European radiology [Eur Radiol] 2021 May; Vol. 31 (5), pp. 2696-2705. Date of Electronic Publication: 2020 Nov 16.